Health Condition 1: I872- Venous insufficiency (chronic) (peripheral)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants presented between C0 and C6 according to CEAP clinical rating. Participants presenting with visible varicose veins with varicose or stasis eczema, varicose ulcers, itching, pain, heaviness, numbness, and swelling in lower limbs. Age above 18 All genders.
Exclusion criteria
Exclusion criteria: Pregnancy, lactating mother, secondary causes of chronic venous disease or varicose veins (abdominal tumors). Any participants presenting with deep vein thrombosis, thrombophlebitis, severe systemic illness, immunocompromised, under the influence of substance abuse, and any psychiatric illness. Participants who need surgical intervention. Participants who refuse to give consent. Participants who are under any other sort of treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in total score of Revised VCSS will signify improvement in signs and symptoms of chronic venous disease.Timepoint: Revised Venous clinical severity score will be evaluated at Baseline, 4 weeks, 8 weeks, 12 weeks till 24 weeks Study Duration 15 months Enrollment period (6 months) Follow-up duration (6 months) Data analysis and report writing (3 months) First dose will be given after case taking and | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in participant quality of life score as measured by validated CIVIQ-20. Timepoint: Quality of life assessment will be done using the CIVIQ-20 questionnaire at Baseline, 4 weeks, 8 weeks, 12 weeks till 24 weeks Study Duration 15 months Enrollment period (6 months) Follow-up duration (6 months) Data analysis and report writing (3 months) | — |
Countries
India
Contacts
Bakson Homoeopathic Medical College And Hospital